KURA
Kura OncologyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
KURA vs peer average
32/100
KURA vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 5 · D 1 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
GERN is the first available peer comparator.
Same-sector, similarly sized biopharma peer in the packet; useful only as a loose small-cap development/commercialization comparison, not a direct AML read-through.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KURA
Kura Oncology
GERN
Geron
Grade
D
C
Momentum
89
87
Value
41
41
Sentiment
53
66
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs GERN
KURA / GERN
Grade Position
Below peers
KURA vs. peer average (D vs. C)
32/100
Momentum
89
KURAValue
41
KURASentiment
53
GERNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KURA
GERN is the first peer returned for this comparison set.